O'Byrne Jason — SEC Form 4 filings
SEC reporting owner CIK 1871145. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-22 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 10,522 shares, $68,927 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 6,799 shares @ $5.56 ($37,782) in Vir Biotechnology, Inc., filed 2025-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | 6 | — | 3 legs · 10,522 sh · $68,927 | 8 |
| Caribou Biosciences, Inc. (CRBU) | Chief Financial Officer | 1 | — | — | 2 |
| Olema Pharmaceuticals, Inc. (OLMA) | CHIEF FINANCIAL OFFICER | 1 | — | — | 1 |
Form 4 filings — O'Byrne Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Vir Biotechnology, Inc. (VIR) | Other (J): 2,500 @ $0 · Other (J): 2,500 @ $0 | EDGAR |
| 2026-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 1,634 @ $9.53 | EDGAR |
| 2026-02-24 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 55,000 @ $0 · Sale (S): 2,089 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 6,799 @ $5.56 | EDGAR |
| 2025-02-25 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Caribou Biosciences, Inc. (CRBU) | Grant/award (A): 33,000 @ $0 · Grant/award (A): 153,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871145 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →